(Press-News.org) NEW ORLEANS – Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.
Advanced melanoma is classified as stage III or IV metastatic melanoma and is a form of skin cancer that has spread from where it originated in the body. TIL therapy represents a significant advancement in cancer care, grounded in decades of dedicated research. TIL therapy works by harnessing the body’s natural defenses in a powerful new way. It is a form of immunotherapy that uses a patient’s own immune cells to fight cancer.
How TIL therapy works
During treatment, surgeons remove a piece of the cancerous tumor and isolate the lymphocytes from the tumor. Lymphocytes are cells that have the ability to identify and fight cancer cells.
In a laboratory, these lymphocytes are activated and multiplied to be administered back into the patient.
Once the TILs are ready, patients are admitted to the hospital to receive a preparative chemotherapy regimen, then the cancer-fighting cells are infused back into the patient. Patients then receive a growth factor, growing an army of lymphocytes to seek out and destroy tumor cells.
The concept of using a patient’s own immune cells to target cancer began to take shape in the late 1980s, when scientists discovered that immune cells found within tumors could recognize and attack cancer. Over the years, this approach has evolved, guided by innovations, and a commitment to improving patient outcomes. The U.S. Food and Drug Administration (FDA) approved the first TIL therapy for advanced melanoma in 2024, following results from clinical trials that show many patients are still responding five years after treatment. These studies illustrated that many patients experienced tumor shrinkage or elimination when other options were not successful. Research continues to study TIL therapy on other types of cancerous tumors, including lung cancer.
“As a care team, we witness firsthand the challenges faced by patients with advanced cancer who have exhausted all conventional treatment options,” said Daniel Johnson, MD, medical oncologist and director of the Center for Innovative Cancer Therapies, Ochsner MD Anderson. “TIL therapy highlights how far cancer treatments have come. By utilizing a patient’s own immune system in a highly personalized manner, we open new options for individuals with metastatic melanoma who have limited treatment choices. Due to the success with melanoma, there are now multiple novel TIL therapies currently being studied in clinical trials to treat other cancers.”
Expert cancer care in the community
Ochsner MD Anderson continues its ongoing commitment to leading edge cancer care, empowering patients and families with access to some of the latest, most promising treatments. Another advanced form of immunotherapy available at Ochsner MD Anderson is CAR T cell therapy, also called Chimeric Antigen Receptor T cell therapy. Ochsner MD Anderson was the first in Louisiana to offer CAR T cell therapy to adults for the treatment of certain blood cancers. In contrast to TIL therapy, CAR T cell therapy collects a patient’s T cells from the blood. These cells are genetically modified to target specific proteins found in cancer cells. This process uses the patient’s immune system to destroy cancer cells.
For more than 80 years, Ochsner has been dedicated to cancer research and new cancer therapy development, bringing innovations to treatment with more clinical trials than anywhere else in Louisiana. It is accredited by the Commission on Cancer of the American College of Surgeons, the American Society of Clinical Oncology, the American College of Radiology, the Foundation for the Accreditation of Cellular Therapy (Bone Marrow Transplant) and the National Accreditation Program for Breast Centers.
Cancer care at Ochsner MD Anderson is recognized by U.S. News & World Report, ranking as high performing in leukemia, lymphoma and myeloma treatment and colon, lung and prostate cancer surgeries. The Ochsner Cancer Institute treats more than 40,000 patients each year and has cared for patients from all 50 states and 28 countries. Each patient’s care team can include as many as 20 multidisciplinary cancer specialists working together to provide high-quality treatment.
To learn more about Ochsner MD Anderson and the treatment options available to patients, please visit ochsner.org/cancerservices.
###
About Ochsner MD Anderson Cancer Center
Ochsner MD Anderson Cancer Center combines the expertise of Ochsner Health, Louisiana’s leader in cancer care, with the world-renowned MD Anderson Cancer Center. As the only fully integrated cancer program in Louisiana based on MD Anderson’s standards and protocols, it offers patients access to cutting-edge treatments, innovative clinical trials, and personalized care plans. With a multidisciplinary team of specialists and advanced technology, Ochsner MD Anderson provides comprehensive care for both common and rare cancers across multiple locations in southeastern Louisiana. This partnership ensures patients receive expert cancer care close to home.
About Ochsner Health
Ochsner Health is the leading nonprofit healthcare provider in Louisiana, Mississippi and across the Gulf South, delivering expert care at its 47 hospitals and more than 370 health and urgent care centers. Ochsner is nationally recognized for inspiring healthier lives and stronger communities through expertise, quality and digital connectivity. In 2024, more than 40,000 dedicated team members and 4,900 employed and affiliated physicians at Ochsner cared for 1.6 million people from every state in the nation and 63 countries. To learn more about how Ochsner empowers people to get well and stay well, visit www.ochsner.org.
END
Ochsner MD Anderson uses groundbreaking TIL therapy to treat advanced melanoma in adults
2026-02-23
ELSE PRESS RELEASES FROM THIS DATE:
A heatshield for ‘never-wet’ surfaces: Rice engineering team repels even near-boiling water with low-cost, scalable coating
2026-02-23
Superhydrophobic surfaces — those famously “never-wet” materials that make water bead up and roll away — have a stubborn weakness: hot water. Once temperatures climb above roughly 40 degrees Celsius, many superhydrophobic coatings abruptly lose their magic. Instead of skittering off, hot droplets start sticking, soaking into the surface texture and leaving behind wet patches and residue.
A new study from mechanical engineers at Rice University describes a surprisingly straightforward ...
Skills from being a birder may change—and benefit—your brain
2026-02-23
Research shows that as individuals learn and acquire a new skill, their brain structure and activity changes. But how do more complex skills involving multiple learning processes influence the brain? New from JNeurosci, researchers led by Erik Wing, from Baycrest Hospital, compared the brains of 29 expert birders with 29 age- and sex-matched beginners. Because birding requires a keen eye, attention, and strong memory, this work may have implications for ...
Waterloo researchers turning plastic waste into vinegar
2026-02-23
Researchers at the University of Waterloo have discovered a way to turn plastic waste into acetic acid, the main ingredient of vinegar, using sunlight.
The breakthrough offers a promising new approach to reducing plastic pollution through photocatalysis, while simultaneously creating a useful, value-added chemical product through a process inspired by nature.
“Our goal was to solve the plastic pollution challenge by converting microplastic waste into high-value products using sunlight,” said Dr. Yimin Wu, a professor of mechanical and mechatronics engineering and ...
Measuring the expansion of the universe with cosmic fireworks
2026-02-23
Munich astronomers image and model extremely rare gravitationally lensed supernova
Measuring the expansion of the universe with cosmic fireworks
An image that could solve a long lasting cosmic mystery
Unprecedented chance to measure the growth of the universe
Collaboration between TUM, LMU and Max Planck Institutes
That the universe is expanding has been known for almost a hundred years now, but how fast? The exact rate of that expansion remains hotly debated, even challenging the standard model ...
How horses whinny: Whistling while singing
2026-02-23
A horse’s whinny is an unusually distinctive mix of sounds including both high and low frequencies. Reporting in the Cell Press journal Current Biology on February 23, researchers demonstrate how horses produce high-frequency sounds that defy their large size while simultaneously producing lower tones: they whistle through their larynx while vibrating their vocal folds as a human does while singing. Horses likely ...
US newborn hepatitis B virus vaccination rates
2026-02-23
About The Study: The findings of this study indicate declines of more than 10 percentage points in newborn hepatitis B virus (HBV) vaccination in the last 2 years, following 6 years of growth. These estimates derived from large-scale hospital and clinic electronic health records align with WHO and CDC coverage through 2022 and provide interim surveillance for 2023-2025, a period not yet reflected in national or global reports.
Corresponding Author: To contact the corresponding author, Joshua M. Rothman, MD, MS, email jmrothman@health.ucsd.edu.
To access the embargoed study: ...
When influencers raise a glass, young viewers want to join them
2026-02-23
An attractive influencer couple chats in a kitchen as they prepare dinner. A wine bottle sits on the counter. Someone takes a sip. It looks less like an ad than a slice of ordinary life, the kind of moment that can pass unnoticed during an aimless scroll on social media.
But a randomized experiment from Rutgers Health and Harvard University suggests those casual cues matter. Young adults who viewed influencer posts with alcohol were significantly more likely to desire a drink than peers who watched similar posts – from the same influencers – with no alcohol involved.
The study in JAMA Pediatrics, led by Jon-Patrick Allem, an associate professor at the Rutgers School ...
Exposure to alcohol-related social media content and desire to drink among young adults
2026-02-23
About The Study: Exposure to alcohol-promoting social media content was associated with desire to drink across varying levels of prior alcohol use, and social media influencers may contribute to normalization of alcohol consumption among young people. This experimental evidence adds to a growing body of research showing that exposure to alcohol-promoting content, particularly on social media, is associated with alcohol-promoting attitudes and behaviors in young adults.
Corresponding Author: To contact the corresponding author, Jon-Patrick Allem, PhD, MA, email jon.patrick.allem@rutgers.edu.
To ...
Access to dialysis facilities in socioeconomically advantaged and disadvantaged communities
2026-02-23
About The Study: This study found that as community disadvantage increased, access to dialysis facilities decreased in a stepwise fashion. Patients with end-stage kidney disease in socioeconomically disadvantaged communities had significantly fewer options for receiving hemodialysis and were more likely to live in areas without nearby dialysis facilities.
Corresponding Author: To contact the corresponding author, Renee Y. Hsia, MD, MSc, email renee.hsia@ucsf.edu.
To access the embargoed study: Visit our For The Media website at this ...
Dietary patterns and indicators of cognitive function
2026-02-23
About The Study: The results of this study reveal that healthy diets, exemplified by the Dietary Approaches to Stop Hypertension (DASH) diet for blood pressure control and diets with lower hyperinsulinemia and inflammation potentials, were associated with a lower subjective cognitive decline risk and better cognitive function. These findings underscore the importance of a healthy diet for maintaining long-term cognitive health.
Corresponding Authors: To contact the corresponding authors, email Changzheng Yuan, ScD, (chy478@zju.edu.cn) and Kjetil ...